A Phase I Study of Perifosine + Capecitabine for Patients With Advanced Colon Cancer

Trial Profile

A Phase I Study of Perifosine + Capecitabine for Patients With Advanced Colon Cancer

Completed
Phase of Trial: Phase I

Latest Information Update: 05 Jun 2015

At a glance

  • Drugs Perifosine (Primary) ; Capecitabine
  • Indications Colon cancer
  • Focus Adverse reactions
  • Sponsors AEterna Zentaris Inc
  • Most Recent Events

    • 27 Feb 2013 Additional lead trial centre identified as reported by ClinicalTrials.gov.
    • 17 Oct 2011 Actual end date (Oct 2011) added as reported by ClinicalTrials.gov.
    • 17 Oct 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top